194 related articles for article (PubMed ID: 17683947)
1. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947
[TBL] [Abstract][Full Text] [Related]
2. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
[TBL] [Abstract][Full Text] [Related]
3. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
[TBL] [Abstract][Full Text] [Related]
4. Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Wischhusen J; Waschbisch A; Wiendl H
Semin Cancer Biol; 2007 Dec; 17(6):459-68. PubMed ID: 17768067
[TBL] [Abstract][Full Text] [Related]
5. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO
Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777
[TBL] [Abstract][Full Text] [Related]
6. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
7. Structure, expression and function of HLA-G in renal cell carcinoma.
Seliger B; Schlaf G
Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
[TBL] [Abstract][Full Text] [Related]
8. Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia.
Perez-Chacon G; Rosado S; Rebolleda N; Losada-Fernandez I; Vargas JA; Morado M; Jorda J; Perez-Aciego P
Int J Lab Hematol; 2009 Jun; 31(3):327-37. PubMed ID: 18241213
[TBL] [Abstract][Full Text] [Related]
9. HLA-G expression in hematologic malignancies.
Yan WH
Expert Rev Hematol; 2010 Feb; 3(1):67-80. PubMed ID: 21082935
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
11. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
12. Is immune escape via human leukocyte antigen expression clinically relevant in chronic lymphocytic leukemia? Focus on the controversies.
Guillaume N; Marolleau JP
Leuk Res; 2013 Apr; 37(4):473-7. PubMed ID: 23347904
[TBL] [Abstract][Full Text] [Related]
13. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.
Yan WH; Fan LA
Cell Res; 2005 Mar; 15(3):176-82. PubMed ID: 15780179
[TBL] [Abstract][Full Text] [Related]
14. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
Rouas-Freiss N; Moreau P; Menier C; LeMaoult J; Carosella ED
Semin Cancer Biol; 2007 Dec; 17(6):413-21. PubMed ID: 17881247
[TBL] [Abstract][Full Text] [Related]
15. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
16. The role of HLA-G in gastrointestinal inflammatory disease and malignancy.
Downs-Kelly E; Schade AE; Hansel DE
Semin Cancer Biol; 2007 Dec; 17(6):451-8. PubMed ID: 17716911
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen-G in cancer: are they clinically relevant?
Yan WH
Cancer Lett; 2011 Dec; 311(2):123-30. PubMed ID: 21843913
[TBL] [Abstract][Full Text] [Related]
18. Non-classical HLA-G antigen and its role in the cancer progression.
Tripathi P; Agrawal S
Cancer Invest; 2006 Mar; 24(2):178-86. PubMed ID: 16537188
[TBL] [Abstract][Full Text] [Related]
19. [HLA-G: an immunoregulatory non classical class I HLA molecule].
Ksouri H; Bardi R; Mellouli F; Bejaoui M
Arch Inst Pasteur Tunis; 2009; 86(1-4):27-38. PubMed ID: 20707218
[TBL] [Abstract][Full Text] [Related]
20. Structural studies on HLA-G: implications for ligand and receptor binding.
Clements CS; Kjer-Nielsen L; McCluskey J; Rossjohn J
Hum Immunol; 2007 Apr; 68(4):220-6. PubMed ID: 17400055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
